[Clinico-morphological indices of patients with nonspecific ulcerative colitis who used an interferon ointment]. 1985

T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D003106 Colon The segment of LARGE INTESTINE between the CECUM and the RECTUM. It includes the ASCENDING COLON; the TRANSVERSE COLON; the DESCENDING COLON; and the SIGMOID COLON. Appendix Epiploica,Taenia Coli,Omental Appendices,Omental Appendix,Appendices, Omental,Appendix, Omental
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004733 Enema Insertion of a solution or compound through the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures. Enemata,Enemas,Enematas
D005260 Female Females

Related Publications

T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
October 1969, Klinicheskaia meditsina,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
January 1964, Vestnik rentgenologii i radiologii,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
February 1978, Klinicheskaia meditsina,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
January 1986, Vestnik rentgenologii i radiologii,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
April 1986, Pediatriia,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
October 1960, Missouri medicine,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
October 1970, Klinicheskaia meditsina,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
January 1979, Arkhiv patologii,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
May 1969, Klinicheskaia meditsina,
T V Zhernakova, and V K Prigozhina, and I V Mal'tseva, and N A Kashmenskaia, and E I Romanova
May 1969, Fel'dsher i akusherka,
Copied contents to your clipboard!